NIH R01 · 2024
Translating buccal nanocytology for lung cancer screening into clinical practice
The overarching goal of this Academic-Industrial Partnership is to develop an at-home, self-administered lung cancer screening test based on the analysis of chromatin architecture in cells swabbed from the buccal (cheek) mucosa, which can identify patients at risk for early-stage lung cancer who may benefit from definitive follow up evaluation such as CT. Lung cancer mortality depends on stage at diagnosis. The combination of recently developed immunotherapy, chemoradiation, and robotic surgery has led to the near curation of cancers detected at early stages such as IA. However, most patients are still diagnosed at late stages. Current screening guidelines recommend all patients with…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.